证券日报网12月16日讯联化科技（002250）在回答调研者提问时表示，部分植保产品专利到期整体上对 公司冲击有限，这主要得益于公司"大客户战略"和CDMO模式的支撑。即使特定产品专利到期，根据公 司与核心客户签订的长期框架协议，相关产品仍将仅向协议客户供应，这种深度绑定保障了业务的稳定 性。同时，公司在长期为客户提供CDMO服务时，不断进行生产优化，降本增效，提升产品的市场竞争 力。另一方面，公司亦正通过建设马来西亚基地等举措，将产能重点投向新的专利期内产品，以持续驱 动增长。 ...

Core Viewpoint - Company adheres to the CDMO model, aiming to provide long-term, reliable, and competitive chemical solutions to clients rather than just individual products or technologies [1] Group 1 - Company has over ten years of production history for Kamine products, indicating a strong foundation in this area [1] - A significant portion of the company's products are still under patent protection, showcasing its commitment to innovation and proprietary technology [1]

Group 1: Supply Chain and Market Strategy - The company is addressing supply chain risks due to the US-China trade war by gradually establishing a global supply chain and acquiring a UK base for production and delivery [1] - The company has developed potential raw material service project proposals for clients, bridging multiple supply chains [1] - The company aims to enhance its service capabilities in the pharmaceutical sector by diversifying its client base and reducing reliance on single large customers [2] Group 2: Financial Performance and Market Position - The company reports that over 50% of its revenue comes from its top five clients, indicating a strong client retention strategy [3] - The pharmaceutical segment is expected to see significant growth as more innovative drugs enter the market, which will improve the gross margin [8] - The company anticipates that the gross margin in the pharmaceutical sector will continue to rise due to a decrease in chemical raw material prices in 2024 [8] Group 3: Product Development and Innovation - The company is focusing on developing innovative agricultural products primarily for overseas clients, emphasizing efficiency and safety [6] - The company is committed to enhancing its CDMO model and expanding its product offerings in the agricultural sector [4] - The company is actively developing new additives in the lithium market, although specific products remain confidential [8] Group 4: Capacity and Production Challenges - The company acknowledges that its current production capacity and utilization rates are not optimal, but plans to improve this as business grows [12] - The company is strategically planning for future capacity expansions to meet anticipated demand [12]